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Background: Dry eye syndrome (DES) is a common ocular disorder occurring in general population. The purpose
of this study is to evaluate the impact of DES on vision-related quality of life (QoL) in a non-clinic-based general
population.
Methods: This population-based cross-sectional study enrolled subjects older than 40 years, who took part in an
epidemiological study on dry eye in Sanle Community, Shanghai. Apart from the collection of sociodemographics,
dry eye symptoms, and other clinical data, a Chinese version of the 25-item National Eye Institute Visual
Functioning Questionnaire (NEI VFQ-25) was administered to all subjects. Comparisons of the NEI VFQ-25 subscale
item scores and composite score were made among subgroups divided according to the presence of dry eye
symptoms or signs. Multivariate regression analysis was performed to investigate the relationship between the
clinical variables and the VFQ-25 composite score.
Results: A total of 229 participants were enrolled in the study, with an average age of (60.7 ±10.1) years old.
Majority of these participants were female (59.8 %, 137/229). The total DES symptom scores (TDSS) in subjects either
with definite DES or only with dry eye symptoms were significantly higher (F = 60.331, P< 0.001). The values of tear
break-up time (TBUT) and Schirmer test were significantly lower in participants with DES and those with dry eye
signs only (F = 55.158 and 40.778, P< 0.001). The composite score of the NEI VFQ-25 was significantly lower in
subjects with DES (F = 4.901, P = 0.003). Moreover, the subscale scores of ocular pain and mental health were
significantly lower in those with either DES or dry eye symptoms only (F = 10.962 and 7.362 respectively, both
P< 0.001). The multiple regression analysis showed that the TDSS had a significant negative correlation with the
VFQ-25 composite score as well as with the subscale score for ocular pain and mental health, even after the
adjustment of all other factors (all P< 0.01).
Conclusions: The symptoms of dry eye are associated with an adverse impact on vision-related QoL in non-clinic-
based general population, which is mainly represented as more ocular pain and discomfort, and impaired mental
health as well. Apart from clinical examination, it is also important to refer to subjective symptoms and QoL scores
when assessing the severity of DES.
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Dry eye syndrome (DES) is a multifactorial disease of
tear and ocular surface, which can cause symptoms of
discomfort, visual disturbance, and tear film instability
[1]. The estimated prevalence of DES in Chinese popula-
tion has been reported to be ranging from 21 % to
50.1 % in adult aged 40 years or older [2-5]. In recent
years, DES has been recognized as a growing public
health problem and one of the most frequent reasons for
seeking eye care.
The medical treatment and clinical studies performed
on DES have conventionally focused mainly on
physician-based outcomes, such as the improvement of
epithelium healing and tear film stability [6,7]. However,
recent and improved understanding of the pathogenesis
and therapeutic targets of DES has encouraged increased
awareness of this disease among patients and clinicians,
stimulating increased recognition of DES-associated
impairments in quality of life (QoL). QoL broadly
encompasses physical, social/role, psychological/emo-
tional, and cognitive functioning concepts. QoL mea-
sures patient-reported data that may not be obtained
through objective measures. In general, vision-related
QoL is an important outcome in the evaluation of thera-
peutic decisions as well as in the assessment of the im-
pact of any ocular condition on economic and public
health.
The 25-item National Eye Institute Visual Function
Questionnaire (NEI-VFQ), a method designed for the
study of vision-specific QoL, has been employed in sev-
eral DES research that are mainly focused on outpatients
diagnosed with DES [8-10]. Nevertheless, the import-
ance of DES on QoL has been underestimated to some
extent because only those with relatively severe DES and
seeking doctors’ help have been investigated heretofore.
However, DES is a common ocular surface disease. To
the best of our knowledge, its impact on QoL in
non–clinic-based general population has not been previ-
ously reported. In view of this, we performed a
population-based research focused on the QoL of sub-




The present study is a part of the nationwide epidemio-
logical study on dry eye. A population-based survey per-
formed among subjects that are ≥ 18 years old in Sanle
Community, Shanghai, China was conducted between
March 15, 2010 and June 30, 2010. Sanle community is
located in Jing’an district, the central region of Shanghai.
It was chosen as the study community on the basis of its
metropolitan location, population stability, and support
from local government and medical institutions. Thestudy was approved by the ethics committee of Eye, Ear,
Nose and Throat Hospital of Fudan University, and con-
ducted according to the tenets of the Declaration of
Helsinki.
Among the participants of the epidemiological study,
those ≥ 40 years old were enrolled in this study. Subjects
that were found to have the following abnormalities were
excluded: blood pressure higher than 160/95 mmHg,
diabetes mellitus, autoimmune disorder or other sys-
temic disorders, corneal disorders that would probably
affect visual acuity, such as corneal leukoma, pterygium
and corneal ulcer, intraocular pressure(IOP) higher than
21 mmHg or lower than 9 mmHg, lens opacity greater
than grade II according to the Lens Opacity Classifica-
tion System III (LOCSIII), any abnormalities in the fun-
dus photograph, refractive error more than +/−6D, and
history of contact lens wear, allergic conjunctivitis, or
ocular surgery. Those who had been diagnosed with
DES before and treated with either artificial tear or
punctal occlusions were excluded as well. Informed con-
sent was obtained from all enrolled participants.Ocular examination
Before ocular examination, trained interviewers con-
tacted the participants and administered a structured
questionnaire, which included detailed demographic in-
formation (age, gender, educational level, occupation),
history of systematic disorders and ocular diseases, life
style (computer use and air conditioner), and dry eye
symptoms. The questions regarding dry-eye symptoms,
which had previously been used by Schein et al. [11],
consisted of six items: (1) Do your eyes ever feel dry? (2)
Do you ever feel a gritty or sandy sensation in your eyes?
(3) Do your eyes ever have a burning sensation? (4) Are
your eyes ever red? (5) Do you notice much crusting on
your lashes? and (6) Do your eyelids ever get stuck? For
each question, the participants were asked to choose
among the following answers: never, rarely, sometimes,
often, or all the time, which were scored as 0, 1, 2, 3 and
4 accordingly. Total DES symptom score (TDSS) was
calculated by the interviewers according to the method
reported previously [12].
All subjects underwent a complete ophthalmologic
examination, including best-corrected visual acuity, sli-
tlamp biomicroscopy, direct ophthalmoscopy, fundus
photography, tonometry, and optometric examination.
All pieces of equipment were transported to a local
medical unit for the convenience of the participants.
The best corrected visual acuity (BCVA) was evaluated
with the LogMAR visual acuity chart. Noncontact ton-
ometer rather than Goldmann applanation tonometer
was used to measure IOP so as to avoid the impact on
corneal epithelium and fluorescence staining.
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time test (TBUT), fluorescein staining score (FSS) of the
cornea, Schirmer I test (ST) and slit-lamp assessment of
anterior segment. The examination was performed in
conformity to the procedures described in previous re-
port [3]. The ophthalmologists performing the eye
examinations were blinded to the dry eye information
found in the questionnaire.
Diagnostic criteria of DES and division of participants
Dry eye was defined as the simultaneous presence of sig-
nificant symptoms and at least one sign. Subjects were
considered symptomatic when at least one of the symp-
toms mentioned in the questionnaire was experienced
often or all the time. Objective tests were considered
indicative of signs in the following instances: ST
score ≤ 5 mm, TBUT ≤ 10 seconds, and FSS ≥ 1. These
criteria had to be met in at least one eye. Subjects with
definite dry eye were classified as group A. The asymp-
tomatic subjects—those only with signs of DES—were
defined as type I suspected DES (group B). Those who
reported significant symptoms but had no signs of DES
were considered as type II suspected DES (group C).
The participants were classified into group D if they
had neither dry eye symptoms nor signs.
Visual Function Questionnaire (VFQ-25)
A Chinese version of the VFQ-25, which was used in the
previous research [13,14], was administered to all the
enrolled subjects. All subjects were requested to fill up
the questionnaire by themselves. The research staff
explained the questionnaire to the participants and pro-
vided assistance when required. For the illiterate partici-
pants, the research staff read the questionnaire for them
in a neutral and uniform manner and recorded the
patients’ choices. The completed questionnaires were
reviewed by the research staff to ensure no data were
missing.
NEI VFQ-25 with an additional question, being trans-
lated into Chinese, was used in the current study to
evaluate the vision-specific QoL. Since the response rate
of No.14 item was rather low in Chinese population
[13], we chose item A8 from NEI-VFQ39 to serve as the
appendix of No.14 item according to the instruction of
the NEI-VFQ25 manual. If the statistical analysis showed
a low response rate of No. 14 item in the current study,
the result of its appendix would be used so as to alleviate
the impact of high miss rate of No.14 item on the valid-
ity and reliability of the whole questionnaire. Each item
in the questionnaire was assigned to one of the 12 sub-
scales: general health, general vision, ocular pain, near
activities, distance activities, social functioning, mental
health, role difficulties, dependency, driving, color vision
and peripheral vision. Answers to each question on theVFQ-25 were converted to a 100-point scale in which
100 represent the best possible score or the minimal
subjective impairment, and 0 represent the worst or the
maximal. The guidelines published by the NEI were
adhered to when calculating the above scale conversions
and subscale scores.Statistical analysis
The mean scores and standard deviations were calcu-
lated for each VFQ-25 subscale and composite score.
ANOVA and Chi-square test was used to analyze the
age, gender distribution, educational level, occupation
and use of computer and air conditioner among the four
groups. ANOVA was used to compare each VFQ-25 sub-
scale score and the composite score among the four
groups, and Post Hoc Tests were further performed to
determine the difference between every two groups. In
addition, multivariate regression analysis was performed
to investigate the relationship between the clinical vari-
ables and the VFQ-25 scores. The covariates tested were
age, gender, educational level, occupation, BCVA of the
eye with more severe DES, BCVA of the eye with less
severe DES or without DES, computer use, use of air
conditioner, TDSS, TBUT, ST and FSS. All tests of associ-
ation were considered statistically significant at P <0.05
(SPSS for Windows, version 13.0; SPSS, Inc., Chicago, IL).Results
The number of residents in Sanle Community was 1686,
as recorded in the household registration system. A total
of 1335 residents took part in the epidemiological study
on DES,with a response rate of 79.2 %. The number of
those aged 40 years and older was 749. Of this number,
229 were eligible and enrolled in the study of DES on
QoL based on the inclusion criteria.
The demographic data of the enrolled participants are
listed in Table 1. No significant difference can be found
among the four subgroups in terms of average age, occu-
pation, and educational level of participants. However,
gender distribution was significantly different among the
four subgroups, with group A and C having more female
participants (X2 = 10.823, P = 0.013).
BCVA, IOP, TDSS, TBUT, ST, and FSS of the four
groups are listed in Table 2. Statistically significant dif-
ferences could be found in neither BCVA nor IOP
among the four subgroups. The TDSS of group A and
group C were significantly higher than those of group B
and group D (F= 60.331, P< 0.001). Moreover, signifi-
cantly lower values of TBUT were found in group A and
group B compared with group C and group D (F= 55.158,
P< 0.001). The comparisons on the ST showed similar
results (F = 40.778, P< 0.001). No significant difference
was found in FSS among the four groups.
Table 1 Demographic data of enrolled participants
feature total (n = 229) group A (n= 70) group B (n= 50) group C (n = 49) group D (n =60)
sex male 92 26 26 11 29
female 137 44 24 38 31
age(yrs) average 60.7 ± 10.1 61.8 ± 9.91 61.6 ± 10.6 59.6 ± 10.9 59.5 ± 9.0
range 41-86 43-85 41-86 42-83 41-83
occupation employed 46 (20.1 %) 17 9 9 11
unemployed 12 (5.2 %) 3 3 4 2
retired 171 (74.7 %) 50 38 36 47
education primary school 10 (4.4 %) 3 2 1 4
junior middle school 15 (6.5 %) 4 4 4 3
senior middle school 163 (71.2 %) 51 33 34 45
university 31 (13.5 %) 4 10 9 8
post-graduate 10 (4.4 %) 8 1 1 0
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in Table 3, ranging from 61.0 for general health to 96.5 for
color vision. The mean composite score was 89.4± 14.2.
Since the missing rate of driving subscale was rather high
(219/229, 95.6 %), we omitted this subscale in the calcula-
tion of the composite score and further analysis according
to the suggestion of previous research [13].
The composite score was significantly lower in group
A, compared with group B and group D (F = 4.901,Table 2 BCVA, IOP, TDSS, TBUT, ST and FSS of four subgroup
group A (n = 70) group B (n = 5
BCVA
right eye 0.23 ± 0.20 (0.16) 0.23 ± 0.22 (0.2
left eye 0.27 ± 0.28 (0.2) 0.24 ± 0.22 (0.2
IOP
right eye 15.33 ± 4.61 (15) 15.86 ± 3.99 (15
left eye 15.21 ± 4.55 (15) 16.17 ± 4.21 (16
TDSS
right eye 6.74 ± 4.29 (6) 0.64 ± 1.24 (0)*
left eye 6.68 ± 4.64 (6) 0.59 ± 1.19 (0)*
TBUT (s)
right eye 4.74 ± 3.54 (3)* 4.08 ± 3.29 (3)*
left eye 4.33 ± 3.08 (3)* 4.52 ± 3.01 (4)*
ST (mm)
right eye 4.11 ± 3.75(3)* 6.22 ± 4.30 (5)*
left eye 4.20 ± 3.33(3)* 5.94 ± 4.19 (5)*
FSS
right eye 0.04 ± 0.27 (0) 0
left eye 0.04 ± 0.27 (0) 0.02 ± 0.14 (0)
The data were expressed as mean ± SD, with the median in the bracket.
* means P value less than 0.001.
BCVA: Best corrected visual acuity, IOP: intraocular pressure, TDSS: total DES sympto
staining score.P= 0.003). The analysis on each subscale score among
the four subgroups revealed significant differences in the
scores of ocular pain and mental health, which were sig-
nificantly lower in group A and C, as shown in Table 4
(F = 10.962 and 7.362 respectively, both P< 0.001). The
result of multiple regression analysis is listed in Table 5
and it shows that the TDSS has a significant correlation
with the VFQ-25 composite score, as well as with the
subscale score for ocular pain and mental health, evens
0) group C (n = 49) group D (n = 60)
) 0.26 ± 0.27 (0.24) 0.25 ± 0.27 (0.2)
) 0.24 ± 0.19 (0.2) 0.24 ± 0.23 (0.2)
) 16.15 ± 5.51 (16) 16.22 ± 4.49 (16)
) 15.52 ± 4.68 (15) 14.93 ± 5.73 (15)
5.90 ± 3.81 (6) 0.36 ± 0.73 (0)*
5.98 ± 3.46 (6) 0.35 ± 0.79 (0)*
10.25 ± 2.47 (10) 9.98 ± 2.41(9)
10.11 ± 2.60 (10) 10.17 ± 2.22(10)
11.47 ± 4.27 (10) 12.17 ± 4.52 (12)
11.58 ± 5.12 (9) 12.25 ± 4.47 (12)
0 0
0 0
m score, TBUT: tear-film breakup time test, ST: Schirmer test, FSS: fluorescein
Table 3 The mean scores for each subscale and
composite score of VFQ-25 in all subjects
subscale average± SD
General Health (n = 229) 60.5 ± 14.1
General Vision (n = 229) 67.8 ± 12.0
Ocular Pain (n = 229) 87.4 ± 17.6
Near activity (n = 229) 85.9 ± 16.2
Distance activity (n = 229) 94.2 ± 12.0
Social function (n = 229) 96.3 ± 11.1
Mental health (n = 229) 87.4 ± 18.2
Role difficulties (n = 229) 88.7 ± 21.5
Dependency (n = 229) 93.3 ± 17.5
Color vision (n = 229) 96.5 ± 11.7
Peripheral vision (n = 229) 95.9 ± 12.3
driving (n = 10) 99.2 ± 2.6
Composite score (n = 229) 89.4 ± 14.2
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Meanwhile, none of the other clinical factors had a sig-
nificant correlation with the VFQ-25 composite score.Discussion
The impact of DES on QoL was rather underestimated
because it tended not to be a common cause of perman-
ent visual morbidity compared with other ocular dis-
eases, such as cataract, glaucoma and age-related
macular degeneration. Consequently, the proportion to
seek medical treatment is fairly low in Chinese elderly
population, especially those with mild and moderate
DES. However, the higher incidence of DES in old
people, ever-increasing demands of modern life style
such as computer use and air conditioner, and prolonged
life expectancy in recent year all highlighted theTable 4 The analysis of composite score and each subscale sc
group A (n = 70) group B (n
General Health 57.8 ± 13.5 60.1 ± 12.9
General Vision 65.5 ± 13.8 70.5 ± 9.6
Ocular Pain 78.9 ± 21.3 } 92.2 ± 14.4
Near activity 81.8 ± 19.0 86.7 ± 13.7
Distance activity 91.2 ± 15.3 94.3 ± 11.5
Social function 93.6 ± 15.2 96.6 ± 10.6
Mental health 80.2 ± 23.4{ 92.3 ± 12.8
Role difficulties 84.7 ± 22.7 91.2 ± 20.5
Dependency 90.1 ± 19.3 94.1 ± 16.8
Color vision 93.8 ± 13.9 96.6 ± 15.0
Peripheral vision 93.4 ± 17.6 97.1 ± 8.2
Composite score 85.3 ± 14.5† 91.2 ± 10.6
† P< 0.05, {P< 0.01, } P< 0.001.consequence of DES for vision-related QoL in the gen-
eral population.
It was the first time to report that the composite score
of the participants with DES decreased significantly
compared with those without DES or with suspected
DES, indicating that DES can produce a significantly
negative impact on the overall vision-related QoL in a
non-clinic-based population who didn’t seek medical
care. Moreover, the current study revealed that the sub-
scale score for ocular pain decreased significantly in the
general population with DES or dry eye symptom, which
was in agreement with previous studies focusing on out-
patients diagnosed with DES. It has been reported that
the subscale score for ocular pain ranged from 62.5 to
87.5 in patients with DES, indicating that DES can cause
more ocular pain or discomfort [8,15]. It has been con-
sidered that the adverse impact on QoL caused by DES,
at least partially, resulted from ocular pain, especially in
patients with severe dry eye such as in Sjogren’s syn-
drome [16]. Meanwhile, the application of artificial tears
or other treatment may improve the signs, symptoms,
and QoL associated with DES [17].
Apart from the decreased scores for ocular pain, lower
scores for mental health were also found in the partici-
pants with DES, indicating that the disorder caused ad-
verse impact not only on physical health, but also on
psychological health. Only a few published studies
reported the psychological status of DES subjects, show-
ing that DES subjects were more anxious and depressed
compared with those without DES [18-20]. On one
hand, it is well known that pain or disabilities caused by
chronic disease can induce anxiety and depression [21].
On the other hand, psychosomatic aspects, which in-
clude depression, stress, and anxiety, could affect sub-
jective ocular symptoms and pain perception [22],
forming a vicious cycle. The fact [18] that subjects withore among four subgroups
=50) group C (n = 49) group D (n = 60)
62.9 ± 15.4 62.1 ± 14.6
66.3 ± 11.6 69.5 ± 11.5
84.9 ± 14.5† 94.2 ± 13.1
89.6 ± 13.6 86.6 ± 15.9
95.2 ± 9.8 96.6 ± 8.9
98.2 ± 6.3 97.5 ± 8.5
85.7 ± 17.4 93.0 ± 12.5
85.7 ± 25.1 93.8 ± 16.2
92.9 ± 18.9 96.5 ± 14.1
99.0 ± 5.0 97.5 ± 8.9
96.4 ± 10.2 97.5 ± 8.9
89.5 ± 8.6 92.3 ± 8.3
Table 5 Multivariate regression analysis on the association between total DES symptom score and VFQ-25 composite
score, ocular pain subscale score, as well as mental health subscale score
VFQ-25 composite score ocular pain subscale score mental health subscale score
β P value β P value β P value
Total DES symptom score Model 1 −0.501 <0.001 −0.836 0.001 −0.903 <0.001
Model 2 −0.444 0.003 −0.842 0.001 −0.824 0.002
Model 3 −0.448 0.003 −0.867 <0.001 −0.819 0.002
Model 4 −0.428 0.008 −0.898 0.001 −0.811 0.003
Values of β are standardized regression coefficients:
Model 1, crude.
Model 2, after the adjustment for age, gender, educational level and occupation.
Model 3, after further adjustment for BCVA of the eye with more severe DES, BCVA of the eye with less severe DES or without DES, use of computer, and use of
air conditioner.
Model 4, after further adjustment for TBUT, ST and FFS.
None of the clinical variables adjusted in model 2 to 4 met the 0.0500 significance level for entry into the final model.
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increased clinical anxiety or depression supported the
hypothesis that more severe DES symptoms could cause
more adverse disturbance on mental health and
function.
It’s notable that the symptomatic participants also
reported lower scores for ocular pain and mental health,
even though they didn’t have any definite signs of DES.
Meanwhile, asymptomatic subjects with dry eye signs
reported similar VFQ-25 scores as compared with nor-
mal controls. It highlighted that the symptoms of DES
deviated from signs, and DES symptoms rather than
signs had an overwhelming impact on VFQ scores, just
as shown by the multiple regression analysis. The un-
pleasant symptoms of dry eye, such as burning or sting-
ing, ocular grittiness, foreign body sensation, blurred
vision, and photophobia, and unsatisfying outcome of
palliative treatments could contribute to an impaired
QoL. Previous studies revealed the lack of concordance
between patient-reported symptoms of DES and clinical
parameters (TBUT, ST, and FSS) [23], as well as the ab-
sence of correlation between the objective ocular surface
examination findings and the VFQ-25 or SF-8 scores [4],
which were in agreement with our study. Symptoms,
being the most common motivation for seeking eye care,
should therefore be a critical outcome measure when
assessing treatment effect and improvement of QoL.
Ocular Surface Disease Index (OSDI) [24], a 12-item
questionnaire, is a disease-specific measure that explores
the vision-related function, ocular symptoms, and envir-
onmental triggers related with DES. In contrast, NEI
VFQ-25 is a vision-specific (but not disease-specific)
method to measure QoL. In addition to an overall com-
posite score ranging from 0 to 100 (lower scores indicat-
ing greater impairment), the measure yields general
numerous subscales, including general vision, ocular
pain, near vision, distance vision, social functioning,
mental health, role functioning, dependency, driving,
color vision, and peripheral vision [25]. It has beenshown that the NEI-VFQ scores were moderately to
strongly correlated with scores on the disease-specific
OSDI in patients with Sjogren’s syndrome, suggesting
the measures were similar in their ability to assess im-
pact of dry eye on vision-targeted QoL [16]. However,
the emphasis of these two measures was different to a
certain extent. The OSDI is targeted to assess how much
the symptoms of dry eye affect the patients’ current sta-
tus (i.e., in the past week), while the NEI-VFQ may be
more suited for capturing the overall impact of a chronic
ocular disease on QoL, especially giving consideration to
physical health and psychological health simultaneously
[14].
In the present study, the diagnosis of DES was done
mainly based on both the presence of dry eye symptoms
and clinical assessment, which included decreased TBUT,
reduced values of Schirmer test and positive corneal stain-
ing, according to the criteria of 2007 Dry Eye Work Shop
[1]. However, more recently published studies document
that an increased tear osmolarity is the hallmark of dry eye
disease [26-28]. It has been demonstrated that tear film
osmolarity is the single best marker of disease severity
across normal, mild/moderate, and severe categories, while
other tests, such as Schirmer test without anesthesia,
TBUT, corneal staining, meibomian dysfunction assess-
ment, conjunctival staining, and dry eye symptom ques-
tionnaire, were found to be informative in the more severe
forms of disease [26]. With the consideration that DES se-
verity of the majority subjects in the community popula-
tion was mild or moderate, tear film osmolarity should
have been a better diagnostic tool for differentiating DES
and normal controls, as well as for evaluating disease se-
verity. Unfortunately, the device for the clinical testing of
tear osmolarity, named as TearLab Osmolarity System
[28], had not been available in China when the research
was performed. It is urgently required to apply tear osmo-
larity in further studies involving DES.
Another limitation of the current study is that the status
of meibomian glands had not been examined. Therefore,
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dysfunction (MGD) cannot be discriminated from those
caused by deficient aqueous tear secretion. It has been
reported that no correlation has been found between
Schirmer result and meibomian gland anomalies [5].
Thus, it’s possible that some symptomatic subjects who
have no DES signs can be classified as DES if the assess-
ment of the meibomian glands is carefully performed.
However, due to the fact that no significant differences
had been found in VFQ score between the participants
with DES and those only with DES symptoms, the bias
caused by misclassification could be largely neglected. The
impact of MGD on vision-related QoL and the differences
of QoL between subjects with MGD and other subtypes of
DES merit further investigation.
Conclusions
In conclusion, the result of this population-based study
shows that the symptoms of dry eye are associated with
an adverse impact on vision-related QoL in non-clinic-
based general population, mainly representing as more
ocular pain and discomfort, as well as impaired mental
health. Examination findings remain essential for the as-
sessment of dry eye, but it is also important to refer to
subjective symptoms and QoL scores to supplement the
diagnosis and to evaluate treatment effects. Using certain
measures to popularize public education on the import-
ance of DES will be helpful in improving the QoL of the
general population. The finding adds further insight into
the consideration of DES as a significant public health
problem that deserves further study.
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